Evidence map›Paper›PMID 34103610›Full record

Trial reportScientific reports2021

Lipid profile dysregulation in opium users based on Fasa PERSIAN cohort study results.

Maryam Kazemi, Mina Bazyar, Mohammad Mehdi Naghizadeh, Azizallah Dehghan, Massih Sedigh Rahimabadi, Mahsa Rostami Chijan, Mostafa Bijani, Maryam Zahmatkeshan, Alireza Ghaemi, Nastaran Samimi and 2 more

Erratum issuedOpen access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Maryam KazemiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Mina BazyarDepartment of Dermatology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Mehdi NaghizadehNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Azizallah DehghanNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Massih Sedigh RahimabadiNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Mahsa Rostami ChijanNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Mostafa BijaniNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Maryam ZahmatkeshanNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Alireza GhaemiDepartment of Nutrition, Health Sciences Research Center, Addiction Institute, Faculty of Public Health, Mazandaran University of Medical Sciences, Sari, Iran.
Nastaran SamimiStudent Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
Reza HomayounfarNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran. homayounfar@sbmu.ac.ir.
Mojtaba FarjamNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran. Farjam.md@gmail.com.
Fasa University of Medical Sciences · IRMazandaran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main health problems in many societies is the increased opium abuse, which was found to be correlated with many problems like cardiovascular disease. This study aimed to evaluate the correlation of opium use with blood lipoproteins as the risk factor of CVD. This was a cross-sectional study conducted on participants of the first phase of the PERSIAN Cohort study who were aged between 35 and 70 years old. Demographic characteristics; history of smoking, alcohol, and opium consumption; medical history; and medications were asked and the related checklists were filled out. The levels of physical activity and fat intake were also registered. As well, lipoprotein profiles were investigated by blood sampling. The linear and logistic regression was used to analyze the relationship between opium and lipid profile and the statistical significant level was considered as < 0.05. Among 9300 participants with a mean age of 48.06 ± 9.44 years old, 49.6% of them were men. About 24.1% of the participants used opium. In the linear regression models, unlike TG (β = 2.2, p = 0.36), total cholesterol (β = - 2.5, p = 0.02), LDL (β = - 2.0, p = 0.04), and HDL (β = - 1.0, p = 0.04) were significantly lower in people who used opium compared to the others. In the logistic regression models, abnormal level of LDL (OR = 0.78, p = 0.003) and total cholesterol (OR = 0.82, p = 0.008) were less in people who used opium compared to the others. This study showed that there is a correlation between opium usage and lower levels of total cholesterol and LDL; however, the lower level of HDL in normal range was seen in opium users. Considering the current evidences, most of them showed the increased risks of ischemic heart disease, heart attack, hypertension, cerebrovascular disease, and cancer in opium users. Therefore, Healthcare providers and patients should be noticed about the deleterious effects of opium consumption on various vascular events. In addition, it is necessary for managers and policy makers of the health care system to take the necessary measures to raise the level of awareness and health literacy of the general public about the high-risk side effects of opium use and to take necessary and effective strategies to prevent and reduce its use.

Indexed as

AdultAgedCohort StudiesFemaleHumansIranLipidsMaleMiddle AgedOpium DependenceLipids

Identifiers

PMID34103610
PMCPMC8187592
OpenAlexW3168191827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.